Ausgabe 12/2021
Inhalt (8 Artikel)
Open Access
Nonstatin Drugs (M. Vrablik, Section Editor)
Oral Lipid-Lowering Treatments Beyond Statins: Too Old and Outdated or Still Useful?
Klaus G. Parhofer
Open Access
Nonstatin Drugs (M. Vrablik, Section Editor)
Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors
Angela Pirillo, Alberico L. Catapano, Giuseppe D. Norata
Cardiovascular Disease and Stroke (J. A. Underberg and J. Newman, Section Editors)
Moving the Needle on Atherosclerotic Cardiovascular Disease and Heart Failure with Influenza Vaccination
Bahar Behrouzi, Jacob A. Udell
Nutrition (K. Petersen, Section Editor)
Watermelon and l-Citrulline in Cardio-Metabolic Health: Review of the Evidence 2000–2020
Britt Burton-Freeman, Morganne Freeman, Xuhuiqun Zhang, Amandeep Sandhu, Indika Edirisinghe
Genetics and Genomics (A. Marian, Section Editor)
Gene-Environment Interactions for Cardiovascular Disease
Jaana A. Hartiala, James R. Hilser, Subarna Biswas, Aldons J. Lusis, Hooman Allayee
Statin Drugs (R. Ceska, Section Editor)
Statins and Inflammation
Martin Satny, Jaroslav A. Hubacek, Michal Vrablik
Reviews and New Research Implications (S. Virani, Section Editor)
Highlights of Cardiovascular Disease Studies Presented at the 2021 European Society of Cardiology Congress
Michelle T. Lee, Dhruv Mahtta, Louis Dlouhy, Hunaina Shahab, Mahmoud Al Rifai, Salim S. Virani
Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor)
Differences in the 2020 ESC Versus 2015 ESC and 2014 ACC/AHA Guidelines on the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation
Mohammad Keykhaei, Haleh Ashraf, Sina Rashedi, Hossein Farrokhpour, Behnam Heidari, Shaghayegh Zokaei, Sayna Bagheri, Roham Foroumadi, Sara Asgarian, Aslan Amirian, Shahrokh Karbalai Saleh, Stefan James